Wolverine Trading
MDGL icon

Wolverine Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History

Wolverine Trading’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.24M Buy
5,056
+4,084
+420% +$1.52M ﹤0.01% 2071
2025
Q2 		$292K Buy
972
+307
+46% +$91.5K ﹤0.01% 3501
2025
Q1 		$218K Sell
665
-5,254
-89% -$1.73M ﹤0.01% 3863
2024
Q4 		$1.84M Buy
5,919
+920
+18% +$259K ﹤0.01% 2037
2024
Q3 		$1.06M Buy
4,999
+417
+9% +$107K ﹤0.01% 2298
2024
Q2 		$1.28M Buy
+4,582
New +$1.09M ﹤0.01% 1957
2024
Q1 		– Sell
-4,503
Closed -$1.06M – 4959
2023
Q4 		$1.04M Buy
4,503
+286
+7% +$50K ﹤0.01% 2264
2023
Q3 		$616K Sell
4,217
-5,566
-57% -$1.05M ﹤0.01% 2578
2023
Q2 		$2.15M Buy
9,783
+4,393
+82% +$1.19M ﹤0.01% 1442
2023
Q1 		$1.26M Buy
+5,390
New +$1.47M ﹤0.01% 1707
2022
Q3 		– Sell
-6,565
Closed -$456K – 5033
2022
Q2 		$472K Buy
6,565
+4,071
+163% +$299K ﹤0.01% 2602
2022
Q1 		$248K Sell
2,494
-8,674
-78% -$731K ﹤0.01% 4138
2021
Q4 		$948K Buy
11,168
+6,868
+160% +$564K ﹤0.01% 2683
2021
Q3 		$344K Buy
4,300
+1,860
+76% +$161K ﹤0.01% 4492
2021
Q2 		$237K Buy
2,440
+269
+12% +$31.8K ﹤0.01% 4788
2021
Q1 		$253K Buy
+2,171
New +$253K ﹤0.01% 4694
2020
Q3 		– Sell
-2,075
Closed -$225K – 4899
2020
Q2 		$213K Buy
+2,075
New +$204K ﹤0.01% 3748
2016
Q3 		– Sell
-397
Closed -$4K – 4888
2016
Q2 		$4K Buy
+397
New +$4.76K ﹤0.01% 3942

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Wolverine Trading's MDGL Position: Q3 2025 in Review

Wolverine Trading increased its Madrigal Pharmaceuticals (MDGL) stake by 420% in Q3 2025, buying an estimated $1.52M and bringing the position to 5,056 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2071.

Wolverine Trading first reported a position in MDGL in Q2 2016 and has held it in 18 quarters since. 352 funds tracked by Wall St. Rank hold MDGL as of Q3 2025.

  • Wolverine Trading held 5,056 shares of Madrigal Pharmaceuticals worth $2.24M as of Q3 2025.
  • Wolverine Trading bought 4,084 Madrigal Pharmaceuticals shares in Q3 2025, an estimated $1.52M.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2071 holding.
  • Wolverine Trading first reported a position in Madrigal Pharmaceuticals in Q2 2016 and has held it in 18 quarters since.
  • 352 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.